Kong, S.L.; Feng, Z.; Kim, S.; Ha, E.K.; Kamel, K.; Becich, M.; Luketich, J.D.; Pennathur, A.
Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma. Biomolecules 2025, 15, 678.
https://doi.org/10.3390/biom15050678
AMA Style
Kong SL, Feng Z, Kim S, Ha EK, Kamel K, Becich M, Luketich JD, Pennathur A.
Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma. Biomolecules. 2025; 15(5):678.
https://doi.org/10.3390/biom15050678
Chicago/Turabian Style
Kong, Susan Luozheng, Zihan Feng, Sangmin Kim, Edra K. Ha, Kero Kamel, Michael Becich, James D. Luketich, and Arjun Pennathur.
2025. "Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma" Biomolecules 15, no. 5: 678.
https://doi.org/10.3390/biom15050678
APA Style
Kong, S. L., Feng, Z., Kim, S., Ha, E. K., Kamel, K., Becich, M., Luketich, J. D., & Pennathur, A.
(2025). Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma. Biomolecules, 15(5), 678.
https://doi.org/10.3390/biom15050678